TECX20260717C2.5
TECX Jul 17 2026 2.50 Call (TECX260717C00002500)
option OPRA

Inactive

Mar 16, 2026

30.790.000%(0.00)1

Industry

Research and Development in Biotechnology (except Nanobiotechnology)

Sector

Professional, Scientific, and Technical Services

Profile

clinical stage company focused on delivering step-change cell & gene therapies targeting cancer and rare disease.

Share

Connect with us

.dark-mode .yW46hZ{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .yW46hZ{ color: #333333; background-color: white; border: 2px solid #333333; }TECX20260717C2.5TECX Jul 17 2026 2.50 Call (TECX260717C00002500)option OPRA